Oncogenes and thyroid cancer (Q33931296)

30 July 2017

1 reference

title

Oncogenes and thyroid cancer (English)

1 reference

30 July 2017

1 reference

G Vecchio

1

1 reference

30 July 2017

M Santoro

series ordinal

2

1 reference

30 July 2017

publication date

1 February 2000

1 reference

Clinical Chemistry and Laboratory Medicine

30 July 2017

published in

1 reference

30 July 2017

volume

38

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

113-116

1 reference

The molecular genetics of multiple endocrine neoplasia type 2A and related syndromes

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.017

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.017

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.017

Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.017

Point mutations of ras oncogenes are an early event in thyroid tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.017

High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.017

Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.017

21 January 2018

Identifiers

DOI

10.1515/CCLM.2000.017

1 reference

30 July 2017

1 reference